Copper surfaces in nursing homes could help control norovirus, researchers say
By
Tim Mullaney
Sep 12, 2013
Nursing homes should consider installing more copper surfaces to prevent outbreaks of norovirus among residents and staff, according to new research out of the United Kingdom.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
CVS Health ‘well positioned’ to serve LTC with future COVID-19 vaccine
By
Danielle Brown
Aug 06, 2020
Long-term care facilities that receive pharmacy services from CVS Health should have sufficient access to a COVID-19 vaccine, once one is ready, executives stated Wednesday morning.
Medicare Part D premiums down, CMS says, as administration aims to curtail swelling drug costs
By
Marty Stempniak
Aug 02, 2018
Premiums for nursing home residents’ prescription drug plans have dipped for the second year in a row, in what the administration hopes is a sign that efforts to curb prescription costs might be...
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Larger cells found to respond to injury
By
Kimberly Marselas
Jul 04, 2016
A professor has discovered a healing process that enlarges cells to maintain the function of injured or diseased tissue.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Gout guidance highlights treat-to-target drug therapy
By
Alicia Lasek
May 12, 2020
Experts strongly recommend moving away from a fixed-dose approach to urate lowering therapy in updated guidelines for 2020.
Former SNF employee sentenced to 13 years for resident’s murder
By
Sep 01, 2017
A former employee of an Illinois skilled nursing facility was sentenced Wednesday to 13 years in prison, but is expected to serve only about half that time, after pleading guilty to murder in the death...
Unnecessary hype surrounds new superbug, experts say
Aug 17, 2010
There is no evidence that a new superbug resistant to most antibiotics will be any more dangerous than other known superbugs, according to new reports.